Millennium Pharmaceuticals, Inc. (MLNM)

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)

An SI Board Since February 1997

Posts	SubjectMarks	Bans	Symbol
3044	135	0	MLNM

Emcee: icanpickem	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
2544	Millennium Pharmaceuticals Shares Appear Fairly Valued Peter Kang, 11.03.05, 2:2	Icebrg	-	11/3/2005
2543	Ian, Millennium must do it more than most. They are everywhere. And still they	Icebrg	-	11/3/2005
2542	Erik, Isn't that what every company in the drug or food supplement markets	Ian@SI	-	11/3/2005
2541	I suppose this had been paid for one way or another by Millennium. I wonder how	Icebrg	-	11/3/2005
2540	[Velcade versus lung cancer] An entire supplement of the journal Clinical Lung	tuck	-	11/3/2005
2539	Millennium Announces Clinical Updates at Analyst Day Meeting prnews CAMBRIDGE	Ian@SI	-	11/2/2005
2538	citi: Millennium Pharmaceuticals (MLNM) Citigroup Investment Research October 2	mopgcw	-	11/1/2005
2537	OT - - i just looked it up. their most recent puzzles were 6/5/05, 12/31/04 and	software salesperson	-	10/28/2005
2536	Here's ML's take, dated 10/27 - EDIT - dull as dishwater, like so much o	tom pope	-	10/28/2005
2535	<i>They are the people who publish a series of puzzles on a monthly basis	tom pope	-	10/28/2005
2534	well, it's sort of strange to say that the mechanism is similar and then poi	scaram(o)uche	-	10/28/2005
2533	Velcade successor: MLNM announced that MLN0415 an inhibitor of IKK beta is in la	software salesperson	-	10/28/2005
2532	thanks, quid, tom, John, fred, Rick and Wilder. tom, i, too, am a nytimes cros	software salesperson	-	10/28/2005
2531	Thank Sales, so much, for your high standards and contributions.	keokalani'nui	-	10/28/2005
2530	>> this quarter’s detailed notes will be my last for... << many, ma	scaram(o)uche	-	10/28/2005
2529	Having seen the difficulties Velcade has had penetrating into second- and now fi	Icebrg	-	10/28/2005
2528	Thanks sales. I don't know what "pareil" is (:>) but I have app	fred hayes	-	10/28/2005
2527	piper: MLNM :MLNM Restructures Again 2005-10-27 16:10 (New York) (MLNM - $8.71)	mopgcw	-	10/28/2005
2526	En************joy it John! (I left the asterisks in just to demonstrate what ma	tom pope	-	10/27/2005
2525	"puts me to shame - here I have all the time in the world since I'm ret	John Metcalf	-	10/27/2005
2524	Second that Quid. Nonpareil is indeed the word. EDIT - puts me to shame - here	tom pope	-	10/27/2005
2523	Thank you for your years of public service, non-pareil, sales. Always a pleasur	quidditch	-	10/27/2005
2522	0415 is an ikk beta inhibitor pre-clinical candidate anyone familiar with the	software salesperson	-	10/27/2005
2521	10/27/05 cc notes 1. 3rd q review 35% increase in V sales in US and 16% reduct	software salesperson	-	10/27/2005
2520	Millennium Pharmaceuticals "neutral," target price reduced Thursday,	Icebrg	-	10/27/2005

Go to reply# or date (mm/dd/yy):